1. Home
  2. DVA vs EXPD Comparison

DVA vs EXPD Comparison

Compare DVA & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • EXPD
  • Stock Information
  • Founded
  • DVA 1994
  • EXPD 1979
  • Country
  • DVA United States
  • EXPD United States
  • Employees
  • DVA N/A
  • EXPD N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • EXPD Oil Refining/Marketing
  • Sector
  • DVA Health Care
  • EXPD Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • EXPD Nasdaq
  • Market Cap
  • DVA 15.2B
  • EXPD 16.2B
  • IPO Year
  • DVA 1995
  • EXPD N/A
  • Fundamental
  • Price
  • DVA $147.01
  • EXPD $126.45
  • Analyst Decision
  • DVA Hold
  • EXPD Hold
  • Analyst Count
  • DVA 5
  • EXPD 10
  • Target Price
  • DVA $154.40
  • EXPD $116.88
  • AVG Volume (30 Days)
  • DVA 1.3M
  • EXPD 1.6M
  • Earning Date
  • DVA 05-01-2025
  • EXPD 02-18-2025
  • Dividend Yield
  • DVA N/A
  • EXPD 1.15%
  • EPS Growth
  • DVA 44.61
  • EXPD 14.17
  • EPS
  • DVA 10.73
  • EXPD 5.72
  • Revenue
  • DVA $12,815,550,000.00
  • EXPD $10,600,515,000.00
  • Revenue This Year
  • DVA $5.76
  • EXPD $0.08
  • Revenue Next Year
  • DVA $3.59
  • EXPD $3.24
  • P/E Ratio
  • DVA $13.70
  • EXPD $22.11
  • Revenue Growth
  • DVA 5.56
  • EXPD 13.98
  • 52 Week Low
  • DVA $125.64
  • EXPD $108.36
  • 52 Week High
  • DVA $179.60
  • EXPD $131.59
  • Technical
  • Relative Strength Index (RSI)
  • DVA 41.48
  • EXPD 75.83
  • Support Level
  • DVA $138.64
  • EXPD $116.85
  • Resistance Level
  • DVA $149.06
  • EXPD $119.80
  • Average True Range (ATR)
  • DVA 4.76
  • EXPD 3.33
  • MACD
  • DVA -0.71
  • EXPD 0.78
  • Stochastic Oscillator
  • DVA 42.77
  • EXPD 87.50

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About EXPD Expeditors International of Washington Inc.

Expeditors International of Washington is a non-asset-based third-party logistics provider, focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 34% of consolidated net revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: